Impact BioMedical, Inc. (IBO)

IBO · BiotechSign Pipeline

Pipeline Overview

Therapeutic Focus: Biotech / Pharmasrc

Signal Snapshot

Clinical Trials (ClinicalTrials.gov aggregate)

Catalyst Records

Publications on Record

ClinicalTrials.gov aggregate as of 2026-09-29. Source

Recent Publications

The Persistence of Sex Bias in High-Impact Clinical Research. — J Surg Res (2022) PMID 35687931
Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional Study. — J Gen Intern Med (2015) PMID 25832619

Get real-time catalyst alerts, analyst signals, dilution risk scores, and full pipeline data for Impact BioMedical, Inc..

Full IBO Data Sign Up Free

Primary Sources

Company identity
Therapeutic indication
Clinical trial aggregate
Publication 35687931
Publication 25832619

This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.